Beauty Farm Medical and Health Industry Inc. disclosed that it bought back 40,000 ordinary shares on 24 September 2026 through on-market transactions at prices ranging between HKD 18.38 and HKD 18.69 per share. The volume-weighted average repurchase price was HKD 18.57, bringing total consideration to HKD 0.74 million.

Following the transaction, the company’s outstanding share count (excluding treasury shares) fell by 0.0161% to 247.71 million, while treasury shares increased to 3.88 million. Total issued shares remained unchanged at 251.59 million.

The buyback forms part of a mandate approved on 26 June 2026 that authorises repurchases of up to 24.85 million shares. Including the latest trade, Beauty Farm has repurchased 810,500 shares under this mandate, representing 0.33% of the issued share base at the time the authorisation was granted. Under Hong Kong Stock Exchange rules, the company is now subject to a 30-day moratorium—lasting until 24 October 2026—on issuing new shares or selling treasury shares.